Exodus Point Capital Management, LP Keros Therapeutics, Inc. Transaction History

Exodus Point Capital Management, LP

  • $16.4 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$44.58 - $66.89 $888,925 - $1.33 Million
19,940 New
19,940 $911,000
Q4 2022

Feb 13, 2023
BUY
$39.45 - $51.77 $466,417 - $612,076
11,823 New
11,823 $568,000
Q4 2021

Feb 11, 2022
SELL
$36.95 - $62.89 $589,426 - $1 Million
-15,952 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$29.27 - $43.71 $466,915 - $697,261
15,952 New
15,952 $631,000

Others Institutions Holding KROS

# of Institutions
177
Shares Held
30.1M
Call Options Held
76.8K
Put Options Held
9K
View Full List

About Keros Therapeutics, Inc.

KROS Quotes by TradingView
  • Ticker KROS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,757,000
  • Market Cap $293M
  • Description
  • Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...
More about KROS
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email